Home/Filings/4/0000318306-17-000002
4//SEC Filing

Jeffrey B Davis 4

Accession 0000318306-17-000002

CIK 0000318306other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:32 PM ET

Size

8.0 KB

Accession

0000318306-17-000002

Insider Transaction Report

Form 4
Period: 2017-12-14
Jeffrey B Davis
DirectorChief Executive Officer
Transactions
  • Award

    Stock option (right to buy)

    2017-12-14+20,00020,000 total
    Exercise: $16.00From: 2018-12-14Exp: 2027-12-14Common stock (20,000 underlying)
  • Award

    Stock option (right to buy)

    2017-12-14+60,00060,000 total
    Exercise: $16.00From: 2019-01-14Exp: 2027-12-14Common stock (60,000 underlying)
Footnotes (2)
  • [F1]100% accelerated vesting on change of control.
  • [F2]After twelve months from the Grant Date option vest 2.0833% monthly. All options vested 48 months from Grant Date.

Issuer

ABEONA THERAPEUTICS INC.

CIK 0000318306

Entity typeother

Related Parties

1
  • filerCIK 0001349083

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:32 PM ET
Size
8.0 KB